|
|
-
PASG
Subgroup Genotoxic Impurities Update
Andrew Teasdale, AstraZeneca
-
Creating
an analytical experiment
workspace with a global IT system
Gill Crutchington, GlaxoSmithKline
-
Stability
study management using a global IT system
Gill Crutchington, GlaxoSmithKline
-
An
Integrated Approach to Stability Indicating
Method Development Utilising
Predictive Software and
Automated Systems
Paul Ferguson, Roland Brown, Steven Coombes, Florence Normand
& Olivier Puissegur, Analytical
Research & Development, Pfizer Global Research &
Development, Sandwich
-
Software
Tools in HPLC Method Development
Maggi Tebrake, 3M
-
LIMS-CDS
link Efficiency gains and complexities
David Johnson, Analytical Development, AstraZeneca R& D,
Charnwood
-
How
to roll out a Global LIMS in
only 16 months
George Johnson, Pfizer Global R&
D, Sandwich, UK
-
Developments
in Tablet Automation for 2006
John Gostick GSK Ware R& D, Andy Walsh AZ Charnwood R& D
-
Automation
- the CRO Perspective
Andrew Gibson, Pharmaceutical Analysis,Covance
-
NMR
Imaging: Applications to tablet Formulation
Abdenour Djemai, Merck Sharp & Dohme
-
Challenges
in the Automation of Inhalation Products
Jon Faulkes, Senior Scientist, Analytical Development,
AstraZeneca
R& D Charnwood
-
Application
of NQR (Nuclear Quadrupole Resonance) to Pharmaceutical Analysis
Elizabeth Tate, King's College, London
-
Advances
in Separation Science (Liquid Phase)
Stephen Wren and Pierre Tchelitcheff, AstraZeneca R&D
Macclesfield
|
|
|
|